Massachusetts Financial Services
IRWD icon

Massachusetts Financial Services’s Ironwood Pharmaceuticals IRWD Stock Holding History

Massachusetts Financial Services’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-99,470
Closed -$410K – 900
2024
Q3 		$410K Sell
99,470
-2,409
-2% -$13K ﹤0.01% 825
2024
Q2 		$664K Buy
101,879
+3,419
+3% +$24.2K ﹤0.01% 816
2024
Q1 		$858K Sell
98,460
-217
-0.2% -$2.63K ﹤0.01% 794
2023
Q4 		$1.13M Buy
+98,677
New +$976K ﹤0.01% 766
2023
Q2 		– Sell
-91,973
Closed -$968K – 847
2023
Q1 		$968K Buy
+91,973
New +$1.03M ﹤0.01% 764
2021
Q1 		– Sell
-18,804
Closed -$214K – 938
2020
Q4 		$214K Buy
+18,804
New +$206K ﹤0.01% 871

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Massachusetts Financial Services's IRWD Position: Q4 2024 in Review

Massachusetts Financial Services sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 99,470 shares — an estimated $410K sold.

Massachusetts Financial Services first reported a position in IRWD in Q4 2020 and held it in 6 quarters. The position peaked at $1.13M in Q4 2023. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • Massachusetts Financial Services reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 99,470 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $410K.
  • Massachusetts Financial Services first reported a position in Ironwood Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • Massachusetts Financial Services's Ironwood Pharmaceuticals position peaked at $1.13M in Q4 2023.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on Massachusetts Financial Services's 13F filing for Q4 2024, filed 12 Feb 2025.